|
| |
|
 |
|
|
[DISPLAY PATENT] |
|
|
|
Application no. and date | 99972109.5 (espacenet) (Federated) (European Patent Register), 19991112 | Patent/reg. no. and date | DK/EP 1131104, 20050202 | Publication date | 20010912 | Priority no. and date | SE 9803929, 19981118 | EP pub. no. and date |
EP 1131104 20010912 | Effective date | | Applicant/owner | MEDIVIR AB, Lunastigen 7
S-144 44 Huddinge, SE | Applicant ref. no. | 38035 DK 01 | Inventor | LEKARE, Gunilla, Solhagsgatan 3
S-784 50 Borlänge, SE | Representative | Plougmann Vingtoft A/S, Strandvejen 70, 2900 Hellerup, DK | Opponent | | IPC Class | A61K 47/14 (2017.01) , A61K 47/44 (2017.01) , A61P 31/22 (2006.01) | Title | Antivirale formuleringer, der omfatter propylenglycol og en isopropyl-alkansyreester | Int. application no. | SE1999002043 | Int. publication no. | WO2000029027 | Related patent (certificate) | | Status | Udløbet | Pædiatrisk forlængelse | - | Udløbsdato for pædiatrisk forlængelse | - |
|
|
|
|
 |